comparemela.com

DUBLIN, Ireland, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein dysregulation

Related Keywords

Ireland ,Dublin ,Jennifer Zibuda ,Investor Relations Communications ,Prothena Corporation ,Nasdaq ,Company On Twitter Prothenacorp ,Inducement Incentive Plan ,Nasdaq Global Market ,Investor Relations ,Prothena ,Corporation ,Nnounces ,Inducement ,Migrants ,Under ,Listing ,Mule ,635 ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.